바로가기
메인메뉴로 바로가기
콘텐츠 바로가기
하단메뉴로 바로가기
패밀리사이트 바로가기


진료과

  • 연세암병원-종양내과, 간암센터, 췌장 담도암센터

전문진료분야

  • <종양내과> 췌장암, 담도암, 간암, 뇌종양, 신경내분비종양, 항암약물치료, 신약치료

교육 및 임상 경력

  • 2010-2011  연세의대  세브란스병원  인턴
  • 2011-2015  연세의대  세브란스병원  전공의
  • 2015-2019  한국과학기술원  전문연구요원
  • 2019-2020      연세의대  내과학교실  종양내과  강사
  • 2020-현  재    연세의대  내과학교실  종양내과  임상조교수

학술관련경력

  • 2012 Merit Award 수상, Asian Clinical Oncology Society
  • 2012 구연 발표, 10th International Conference of Asian Clinical Oncology Society
  • 2015 학술상, 한국암학술재단
  • 2019 우수 논문상, 생명과학기술대학, 한국과학기술원
  • 2019 학술상, 연세대학교 의과대학 내과 총 동우회
  • 2020 한국연구재단 신진연구지원사업 수혜

주요 관심분야

  • 항암약물치료, 림프절 전이 기전 연구, 종양대사학

학력사항

  • 2004-2010 연세대학교 의과대학 학사
  • 2012-2014 연세대학교 의과대학 석사
  • 2015-2019 한국과학기술원 의과학대학원 박사

논문

  • C. K. Lee, S. H. Jeong, C. Jang, H. Bae, Y. H. Kim, I. Park, S. K. Kim, G. Y. Koh, Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation. Science 363, 644-649 (2019).
  • Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer
    AMERICAN JOURNAL OF CANCER RESEARCH 5/1 :72-86,2015
  • Prediction of short- and long-term survival for advanced cancer patients after ICU admission
    SUPPORTIVE CARE IN CANCER 23/6 :1647-1655,2015
  • Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
    CANCER RESEARCH AND TREATMENT 74/4 :781-789,2015
  • A Case of von Hippel?Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas
    CANCER RESEARCH AND TREATMENT 48/1 :409-414,2016
  • Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy
    ANNALS OF SURGERY 263/1 :96-102,2016
  • Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab.
    ONCOTARGET 8/19 :31,169-31,179,2017
  • Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer
    ONCOTARGET 8/37 :61,837-61,845,2017
  • Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs
    LUNG CANCER 113/0 :106-114,2017
  • PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer
    ONCOTARGET 8/69 :113,494-113,501,2017
  • The prognostic value of volume-based parameters using 18F-FDG PET/CT in gastric cancer according to HER2 status
    GASTRIC CANCER 21/2 :213-224,2018
  • Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer
    Journal for ImmunoTherapy of Cancer 7/1 :e268-,2019

이충근

콘텐츠 처음으로 이동

네크워크 링크안내/사이트 정보